首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Engineering of Bio-Adhesive Ligand Containing Recombinant RGD and PHSRN Fibronectin Cell-Binding Domains in Fusion with a Colored Multi Affinity Tag: Simple Approach for Fragment Study from Expression to Adsorption
【2h】

Engineering of Bio-Adhesive Ligand Containing Recombinant RGD and PHSRN Fibronectin Cell-Binding Domains in Fusion with a Colored Multi Affinity Tag: Simple Approach for Fragment Study from Expression to Adsorption

机译:含有重组RGD的生物粘合配体和PHSRN纤连蛋白结合域的生物粘合配体的工程与彩色多亲和标签:碎片研究的简单方法从表达吸附

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Engineering of biomimetic motives have emerged as promising approaches to improving cells’ binding properties of biomaterials for tissue engineering and regenerative medicine. In this study, a bio-adhesive ligand including cell-binding domains of human fibronectin (FN) was engineered using recombinant protein technology, a major extracellular matrix (ECM) protein that interacts with a variety of integrins cell-surface’s receptors and other ECM proteins through specific binding domains. 9th and 10th fibronectin type III repeat containing Arginine-Glycine-Aspartic acid (RGD) and Pro-His-Ser-Arg-Asn (PHSRN) synergic site (FNIII9-10) were expressed in fusion with a Colored Multi Affinity Tag (CMAT) to develop a simplified production and characterization process. A recombinant fragment was produced in the bacterial system using E. coli with high yield purified protein by double affinity chromatography. Bio-adhesive surfaces were developed by passive coating of produced fragment onto non adhesive surfaces model. The recombinant fusion protein (CMAT-FNIII9/10) demonstrated an accurate monitoring capability during expression purification and adsorption assay. Finally, biological activity of recombinant FNIII9/10 was validated by cellular adhesion assay. Binding to α5β1 integrins were successfully validated using a produced fragment as a ligand. These results are robust supports to the rational development of bioactivation strategies for biomedical and biotechnological applications.
机译:仿生动机的工程作为提高组织工程和再生医学的生物材料细胞对细胞的结合性能。在该研究中,使用重组蛋白质技术,一种具有重组蛋白质技术的细胞结合蛋白(Fn)的生物粘合剂配体,其主要细胞外基质(ECM)蛋白质与各种整联体细胞表面的受体和其他ECM蛋白相互作用通过特定的绑定域。含有精氨酸 - 甘氨酸 - 天冬氨酸(RGD)和Pro-His-Ser-Arg-ASN(PHSRN)协同位点(FNIII9-10)的第9型和第10型纤连蛋白型重复在融合中以彩色多亲和标签(CMAT)表示开发简化的生产和表征过程。通过双亲和色谱法使用高产纯度蛋白质的大肠杆菌在细菌系统中产生重组片段。通过产生片段的被动涂层在非粘合表面模型上开发生物粘合表面。重组融合蛋白(CMAT-FNIIII9 / 10)在表达纯化和吸附测定期间证明了准确的监测能力。最后,通过细胞粘附测定验证重组FNIII9 / 10的生物活性。使用产生的片段作为配体成功验证到α5β1整合蛋白的结合。这些结果是对生物医学和生物技术应用的生物活化策略的合理开发的强大支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号